BioMarin Pharmaceutical (BMRN) has shared an announcement.
BioMarin Pharmaceutical Inc. will see a leadership transition as Dr. Henry J. Fuchs plans to retire on March 3, 2025. Dr. Greg Friberg is set to take over as Executive Vice President, Chief Worldwide Research and Development Officer on September 30, 2024. Until his retirement, Dr. Fuchs will serve as a senior advisor, ensuring a smooth handover.
Learn more about BMRN stock on TipRanks’ Stock Analysis page.
